|Master Investor Magazine
Never miss an issue of Master Investor Magazine – sign-up now for free!
The share price of AIM-listed neuroscience data specialist IXICO (LON:IXI) has increased by 24.85% to 42.45p (as of 13:00 BST) after the company announced that full-year results will be materially ahead of market expectations. Management said that growth had accelerated during the second half of the year ending 30th September due to new and expanded contracts, the deployment of improved algorithms, and faster turnaround times.
CEO Giulio Cerroni commented: “We are delighted to see continued momentum in our revenue growth, establishing 2019 as an inflexion point in the Company’s progress. This is a fantastic achievement which reflects the Company’s ability to support and grow with the increasing demand for our high quality neurological imaging and data analytics services“.